The glioblastoma vasculature as a target for cancer therapy

Biochemical Society Transactions

Volumn 42, Issue 6, 2014, Pages 1647-1652

  Dimberg, Anna ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Anti angiogenic therapy; Endothelium; Gene expression; Glioblastoma; Tumour; Vascular abnormalization

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CEDIRANIB; PLATELET DERIVED GROWTH FACTOR B; PLEIOTROPHIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANTIANGIOGENIC THERAPY; ARTICLE; CANCER STEM CELL; CARCINOGENESIS; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HYPOXEMIA; MOLECULARLY TARGETED THERAPY; REGULATORY MECHANISM; STEM CELL NICHE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; BRAIN NEOPLASMS; CELL HYPOXIA; PATHOLOGY; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; BRAIN NEOPLASMS; CELL HYPOXIA; GENE EXPRESSION; GLIOBLASTOMA; HUMANS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84911905421     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140278     Document Type: Article

References (61)

1. Phillips, H.S., Kharbanda, S., Chen, R., Forrest, W.F., Soriano, R.H., Wu, T.D., Misra, A., Nigro, J.M., Colman, H., Soroceanu, L. et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9, 157-173 CrossRef PubMed
2. Verhaak, R.G., Hoadley, K.A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M.D., Miller, C.R., Ding, L., Golub, T., Mesirov, J.P. et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17, 98-110 CrossRef PubMed
3. Noushmehr, H., Weisenberger, D.J., Diefes, K., Phillips, H.S., Pujara, K., Berman, B.P., Pan, F., Pelloski, C.E., Sulman, E.P., Bhat, K.P. et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17, 510-522 CrossRef PubMed
4. Brennan, C.W., Verhaak, R.G., McKenna, A., Campos, B., Noushmehr, H., Salama, S.R., Zheng, S., Chakravarty, D., Sanborn, J.Z., Berman, S.H. et al. (2013) The somatic genomic landscape of glioblastoma. Cell 155, 462-477 CrossRef PubMed
5. Louis, D.N., Ohgaki, H., Wiestler, O.D., Cavenee, W.K., Burger, P.C., Jouvet, A., Scheithauer, B.W. and Kleihues, P. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109 CrossRef PubMed
6. Stupp, R., Mason, W.P., van den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U. et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 CrossRef PubMed
7. Omuro, A. and DeAngelis, L.M. (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310, 1842-1850 CrossRef PubMed
8. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186 CrossRef PubMed
9. Leon, S.P., Folkerth, R.D. and Black, P.M. (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77, 362-372 CrossRef PubMed
10. Adams, R.H. and Alitalo, K. (2007) Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464-478 CrossRef PubMed
11. Dimberg, A. (2010) Chemokines in angiogenesis. Curr. Top. Microbiol. Immunol. 341, 59-80 PubMed
12. Ding, Y., Song, N. and Luo, Y. (2012) Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes. Cancer Microenviron. 5, 225-236 CrossRef PubMed
13. Jain, R.K., di Tomaso, E., Duda, D.G., Loeffler, J.S., Sorensen, A.G. and Batchelor, T.T. (2007) Angiogenesis in brain tumours. Nat. Rev. Neurosci. 8, 610-622 CrossRef PubMed
14. Olsson, A.K., Dimberg, A., Kreuger, J. and Claesson-Welsh, L. (2006) VEGF receptor signalling: in control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371 CrossRef PubMed
15. Carmeliet, P. and Jain, R.K. (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473, 298-307 CrossRef PubMed
16. Forsythe, J.A., Jiang, B.H., Iyer, N.V., Agani, F., Leung, S.W., Koos, R.D. and Semenza, G.L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16, 4604-4613 PubMed
17. Plate, K.H., Breier, G., Weich, H.A. and Risau, W. (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-848 CrossRef PubMed
18. Sundberg, C., Nagy, J.A., Brown, L.F., Feng, D., Eckelhoefer, I.A., Manseau, E.J., Dvorak, A.M. and Dvorak, H.F. (2001) Glomeruloid microvascular proliferation follows adenoviral vascular permeability factor/vascular endothelial growth factor-164 gene delivery. Am. J. Pathol. 158, 1145-1160 CrossRef PubMed
19. Massague, J. (2008) TGFβ in cancer. Cell 134, 215-230 CrossRef PubMed
20. Constam, D.B., Philipp, J., Malipiero, U.V., ten Dijke, P., Schachner, M. and Fontana, A. (1992) Differential expression of transforming growth factor-β1,-β2, and-β3 by glioblastoma cells, astrocytes, and microglia. J. Immunol. 148, 1404-1410 PubMed
21. Kjellman, C., Olofsson, S.P., Hansson, O., Von Schantz, T., Lindvall, M., Nilsson, I., Salford, L.G., Sjogren, H.O. and Widegren, B. (2000) Expression of TGF-β isoforms, TGF-β receptors, and SMAD molecules at different stages of human glioma. Int. J. Cancer 89, 251-258 CrossRef PubMed
22. Bruna, A., Darken, R.S., Rojo, F., Ocana, A., Penuelas, S., Arias, A., Paris, R., Tortosa, A., Mora, J., Baselga, J. and Seoane, J. (2007) High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11, 147-160 CrossRef PubMed
23. Dieterich, L.C., Mellberg, S., Langenkamp, E., Zhang, L., Zieba, A., Salomaki, H., Teichert, M., Huang, H., Edqvist, P.H., Kraus, T. et al. (2012) Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. J. Pathol. 228, 378-390 CrossRef PubMed
24. high glioma-initiating cell population in human glioblastoma. Cancer Cell 18, 655-668 CrossRef PubMed
25. Shih, A.H. and Holland, E.C. (2006) Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett. 232, 139-147 CrossRef PubMed
26. Guo, P., Hu, B., Gu, W., Xu, L., Wang, D., Huang, H.J., Cavenee, W.K. and Cheng, S.Y. (2003) Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am. J. Pathol. 162, 1083-1093 CrossRef PubMed
27. Reis, M., Czupalla, C.J., Ziegler, N., Devraj, K., Zinke, J., Seidel, S., Heck, R., Thom, S., Macas, J., Bockamp, E. et al. (2012) Endothelial Wnt/β-catenin signaling inhibits glioma angiogenesis and normalizes tumor blood vessels by inducing PDGF-B expression. J. Exp. Med. 209, 1611-1627 CrossRef PubMed
28. Lindblom, P., Gerhardt, H., Liebner, S., Abramsson, A., Enge, M., Hellstrom, M., Backstrom, G., Fredriksson, S., Landegren, U., Nystrom, H.C. et al. (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev. 17, 1835-1840 CrossRef PubMed
29. Muramatsu, T. (2002) Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. J. Biochem. 132, 359-371 CrossRef PubMed
30. Peria, F.M., Neder, L., Marie, S.K., Rosemberg, S., Oba-Shinjo, S.M., Colli, B.O., Gabbai, A.A., Malheiros, S.M., Zago, M.A., Panepucci, R.A. et al. (2007) Pleiotrophin expression in astrocytic and oligodendroglial tumors and its correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival. J. Neurooncol. 84, 255-261 CrossRef PubMed
31. Powers, C., Aigner, A., Stoica, G.E., McDonnell, K. and Wellstein, A. (2002) Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. J. Biol. Chem. 277, 14153-14158 CrossRef PubMed
32. Muller, S., Kunkel, P., Lamszus, K., Ulbricht, U., Lorente, G.A., Nelson, A.M., von Schack, D., Chin, D.J., Lohr, S.C., Westphal, M. and Melcher, T. (2003) A role for receptor tyrosine phosphatase ζ in glioma cell migration. Oncogene 22, 6661-6668 CrossRef PubMed
33. Koyama-Nasu, R., Haruta, R., Nasu-Nishimura, Y., Taniue, K., Katou, Y., Shirahige, K., Todo, T., Ino, Y., Mukasa, A., Saito, N. et al. (2014) The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells. Oncogene 33, 2236-2244 CrossRef PubMed
34. Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E.A., Stassi, G., Larocca, L.M. and De Maria, R. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature 468, 824-828 CrossRef PubMed
35. Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K.E., Geber, A., Fligelman, B., Leversha, M., Brennan, C. and Tabar, V. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature 468, 829-833 CrossRef PubMed
36. Soda, Y., Marumoto, T., Friedmann-Morvinski, D., Soda, M., Liu, F., Michiue, H., Pastorino, S., Yang, M., Hoffman, R.M., Kesari, S. and Verma, I.M. (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 108, 4274-4280 CrossRef PubMed
37. Kulla, A., Burkhardt, K., Meyer-Puttlitz, B., Teesalu, T., Asser, T., Wiestler, O.D. and Becker, A.J. (2003) Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature. Acta Neuropathol. 105, 328-332 PubMed
38. Rodriguez, F.J., Orr, B.A., Ligon, K.L. and Eberhart, C.G. (2012) Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget 3, 98-106 PubMed
39. Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J.K., Fang, X., Sloan, A.E., Mao, Y., Lathia, J.D. et al. (2013) Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 153, 139-152 CrossRef PubMed
40. Scully, S., Francescone, R., Faibish, M., Bentley, B., Taylor, S.L., Oh, D., Schapiro, R., Moral, L., Yan, W. and Shao, R. (2012) Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J. Neurosci. 32, 12950-12960 CrossRef PubMed
41. Wolburg, H., Noell, S., Fallier-Becker, P., Mack, A.F. and Wolburg-Buchholz, K. (2012) The disturbed blood-brain barrier in human glioblastoma. Mol. Aspects Med. 33, 579-589 CrossRef PubMed
42. Jain, R.K. (2013) Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J. Clin. Oncol. 31, 2205-2218 CrossRef PubMed
43. Wurth, R., Bajetto, A., Harrison, J.K., Barbieri, F. and Florio, T. (2014) CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment. Front. Cell Neurosci. 8, 144 PubMed
44. Wilson, W.R. and Hay, M.P. (2011) Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 11, 393-410 CrossRef PubMed
45. Griffioen, A.W., Damen, C.A., Blijham, G.H. and Groenewegen, G. (1996) Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood 88, 667-673 PubMed
46. Fisher, D.T., Chen, Q., Appenheimer, M.M., Skitzki, J., Wang, W.C., Odunsi, K. and Evans, S.S. (2006) Hurdles to lymphocyte trafficking in the tumor microenvironment: implications for effective immunotherapy. Immunol. Invest. 35, 251-277 CrossRef PubMed
47. Lohr, J., Ratliff, T., Huppertz, A., Ge, Y., Dictus, C, Ahmadi, R., Grau, S., Hiraoka, N., Eckstein, V., Ecker, R.C. et al. (2011) Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-, 6. Clin. Cancer Res. 17, 4296-4308 CrossRef PubMed
48. Huang, H., Langenkamp, E., Georganaki, M., Loskog, A., Fredlund Fuchs, P., Dieterich, L.C., Kreuger, J. and Dimberg, A. (2014) VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-KB-induced endothelial activation. FASEBJ., in the press
49. Calabrese, C, Poppleton, H., Kocak, M., Hogg, T.L., Fuller, C, Hamner, B., Oh, E.Y., Gaber, M.W., Finklestein, D., Allen, M. et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11, 69-82 CrossRef PubMed
50. Shen, Q., Goderie, S.K., Jin, L., Karanth, N., Sun, Y., Abramova, N., Vincent, P., Pumiglia, K. and Temple, S. (2004) Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells. Science 304, 1338-1340 CrossRef PubMed
51. Lathia, J.D., Gallagher, J., Heddleston, J.M., Wang, J., Eyler, C.E., Macswords, J., Wu, Q., Vasanji, A., McLendon, R.E., Hjelmeland, A.B. and Rich, J.N. (2010) Integrin a6 regulates glioblastoma stem cells. Cell Stem Cell 6, 421-432 CrossRef PubMed
52. Charles, N., Ozawa, T., Squatrito, M., Bleau, A.M., Brennan, C.W., Hambardzumyan, D. and Holland, E.C. (2010) Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells. Cell Stem Cell 6, 141-152 CrossRef PubMed
53. Zhang, W., Mojsilovic-Petrovic, J., Andrade, M.F., Zhang, H., Ball, M. and Stanimirovic, D.B. (2003) The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J. 17, 2085-2087 PubMed
54. Pen, A., Moreno, M.J., Martin, J. and Stanimirovic, D.B. (2007) Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels. Glia 55, 559-572 CrossRef PubMed
55. Pen, A., Moreno, M.J., Durocher, Y., Deb-Rinker, P. and Stanimirovic, D.B. (2008) Glioblastoma-secreted factors induce IGFBP7 and angiogenesis by modulating Smad-2-dependent TGF-β signaling. Oncogene 27, 6834-6844 CrossRef PubMed
56. Mustafa, D.A., Dekker, L.J., Stingl, C., Kremer, A., Stoop, M., Sillevis Smitt, P.A., Kros, J.M. and Luider, T.M. (2012) A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma. Mol. Cell. Proteomics 11, M111.008466 CrossRef PubMed
57. Batchelor, T.T., Sorensen, A.G., di Tomaso, E., Zhang, W.T., Duda, D.G., Cohen, K.S., Kozak, K.R., Cahill, D.P., Chen, P.J., Zhu, M. et al. (2007) AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. Cancer Cell 11, 83-95 CrossRef PubMed
58. Paez-Ribes, M., Allen, E., Hudock, J., Takeda, T., Okuyama, H., Vinals, F., Inoue, M., Bergers, G., Hanahan, D. and Casanovas, O. (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15, 220-231 CrossRef PubMed
59. Keunen, O., Johansson, M., Oudin, A., Sanzey, M., Rahim, S.A., Fack, F., Thorsen, F., Taxt, T., Bartos, M., Jirik, R. et al. (2011) Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc. Natl. Acad. Sci. U.S.A. 108, 3749-3754 CrossRef PubMed
60. Sorensen, A.G., Batchelor, T.T., Zhang, W.T., Chen, P.J., Yeo, P., Wang, M., Jennings, D., Wen, P.Y., Lahdenranta, J., Ancukiewicz, M. et al. (2009) A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Res. 69, 5296-5300 CrossRef PubMed
61. Sorensen, A.G., Emblem, K.E., Polaskova, P., Jennings, D., Kim, H., Ancukiewicz, M., Wang, M., Wen, P.Y., Ivy, P., Batchelor, T.T. and Jain, R.K. (2012) Increased survival of glioblastoma patients who respond to antiangiogenic therapy with elevated blood perfusion. Cancer Res. 72, 402-407 CrossRef PubMed